Complimentary vertebrate Wac models exhibit phenotypes relevant to DeSanto-Shinawi Syndrome
Lee, K.-H.; Stafford, A. M.; Pacheco-Vergara, M.; Cichewicz, K.; Canales, C. P.; Seban, N.; Corea, M.; Rahbarian, D.; Bonekamp, K. E.; Gillie, G. R.; Pacheco-Cruz, D.; Gill, A. M.; Hwang, H.-E.; Uhl, K.; Shinawi, M.; Li, X.; Obenaus, A.; Crandall, S. R.; Jeong, J.; Nord, A. S.; Kim, C.-H.; Vogt, D.
Show abstract
Monogenic syndromes are associated with neurodevelopmental changes that result in cognitive impairments, neurobehavioral phenotypes including autism and seizures. Limited studies and resources are available to make meaningful headway into the underlying molecular mechanisms that result in these symptoms. One such example is DeSanto-Shinawi Syndrome (DESSH), a rare disorder caused by pathogenic variants in the WAC gene. Individuals with DESSH syndrome exhibit a recognizable craniofacial gestalt, developmental delay/intellectual disability, neurobehavioral symptoms that include autism, ADHD, behavioral difficulties and seizures. However, no thorough studies from a vertebrate model exist to understand how these changes occur. To overcome this, we developed both murine and zebrafish Wac/wac deletion mutants and studied whether their phenotypes recapitulate those described in individuals with DESSH syndrome. We first show that the two Wac models exhibit craniofacial and behavioral changes, reminiscent of abnormalities found in DESSH syndrome. In addition, each model revealed impacts to GABAergic neurons and further studies showed that the mouse mutants are susceptible to seizures, changes in brain volumes that are different between sexes and relevant behaviors. Finally, we uncovered transcriptional impacts of Wac loss of function in mice that will pave the way for future molecular studies into DESSH. These studies present two new animals that begin to uncover some biological underpinnings of DESSH syndrome and elucidate the biology of Wac.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Aberrant regulation of a poison exon caused by a non-coding variant in Scn1a-associated epileptic encephalopathy 96%
- Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome 96%
- ZNF423 patient variants, truncations, and in-frame deletions in mice define an allele-dependent range of midline brain abnormalities 95%
Similar papers in this journal
Similar papers in this journal
- Neuroanatomy and Behaviour in Mice with a Haploinsufficiency of AT-Rich Interactive Domain 1B (ARID1B) Throughout Development 96%
- Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome 95%
- Targeting the RHOA pathway improves learning and memory in Kctd13 and 16p11.2 deletion mouse models. 92%
Similar papers in this journal
- Oxytocin administration in neonates shapes the hippocampal circuitry and restores social behavior in a mouse model of autism. 94%
- Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome. 94%
- Dysregulation of Neuropilin-2 Expression in Inhibitory Neurons Impairs Hippocampal Circuit Development Leading to Autism-Epilepsy Phenotype 94%